Eam Global Investors LLC Prometheus Biosciences, Inc. Transaction History

Eam Global Investors LLC

  • $435 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$36.06 - $117.21 $1.83 Million - $5.96 Million
-50,863 Reduced 68.96%
22,893 $2.52 Million
Q3 2022

Nov 14, 2022
BUY
$28.17 - $59.01 $2.08 Million - $4.35 Million
73,756 New
73,756 $4.35 Million
Q2 2022

Aug 12, 2022
SELL
$22.39 - $38.94 $1.28 Million - $2.22 Million
-57,073 Closed
0 $0
Q4 2021

Feb 11, 2022
BUY
$22.28 - $39.54 $1.27 Million - $2.26 Million
57,073 New
57,073 $2.26 Million

Others Institutions Holding RXDX

# of Institutions
2
Shares Held
29.6K
Call Options Held
0
Put Options Held
0
View Full List

About Prometheus Biosciences, Inc.

RXDX Quotes by TradingView
  • Ticker RXDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,904,100
  • Description
  • Prometheus Biosciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics and companion diagnostics products for the treatment of inflammatory bowel diseases (IBD). Its lead product includes PRA023, a humanized IgG1 monoclonal antibody (mAb), which is in Phase IIa clinical trial...
More about RXDX
Track This Portfolio

Track Eam Global Investors LLC Portfolio

Follow Eam Global Investors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eam Global Investors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eam Global Investors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email